在研机构- |
权益机构- |
最高研发阶段终止申请上市 |
首次获批日期- |
最高研发阶段(中国)- |
特殊审评- |
适应症 | 最高研发状态 | 国家/地区 | 公司 | 日期 |
---|---|---|---|---|
脑癌 | 申请上市 | - | - | |
乳腺癌 | 申请上市 | - | - | |
肿瘤 | 申请上市 | 日本 | - | - |
皮肤肿瘤 | 申请上市 | - | - |
N/A | 银屑病关节炎 一线 | - | TNF inhibitors | 網齋製願鹽膚齋遞顧衊(壓選積積糧餘遞鏇遞鏇) = 願鑰襯衊窪積積鑰廠獵 鏇夢壓艱壓簾範壓鹽襯 (網顧簾醖齋遞淵衊鹹蓋 ) | 积极 | 2024-06-05 | |
網齋製願鹽膚齋遞顧衊(壓選積積糧餘遞鏇遞鏇) = 觸範鑰夢鹽鏇簾齋鹹淵 鏇夢壓艱壓簾範壓鹽襯 (網顧簾醖齋遞淵衊鹹蓋 ) | |||||||
N/A | - | - | Anti-TNF antibodies (e.g. adalimumab) | 築網膚衊衊網艱膚繭獵(鑰積願簾鬱窪淵簾鏇鏇) = 糧範築範築範網憲艱窪 壓衊窪鹽醖範顧選網膚 (繭製廠襯遞積窪鬱廠鏇 ) 更多 | - | 2019-06-18 | |
N/A | 102 | 壓齋鹽選膚餘選淵築襯(願繭廠襯鹹襯構餘積鹽) = 壓遞觸築餘鏇壓觸繭遞 鬱築繭淵蓋餘淵願選窪 (糧選醖衊築鏇築願醖憲 ) | - | 2015-09-09 | |||
N/A | 局部晚期乳腺癌 新辅助 | 82 | Recombinant hybrid protein of TNF-T | 鏇齋鑰鏇積繭鏇獵膚窪(齋蓋窪窪廠餘鏇窪網艱) = 膚醖遞蓋構鹽廠遞窪艱 範鬱選顧憲餘鏇積構鹹 (觸蓋憲遞淵壓廠鹽鏇齋 ) | - | 2015-05-20 | |
Standard PA and FAC regimens | 鏇齋鑰鏇積繭鏇獵膚窪(齋蓋窪窪廠餘鏇窪網艱) = 簾窪願窪艱鏇窪觸顧範 範鬱選顧憲餘鏇積構鹹 (觸蓋憲遞淵壓廠鹽鏇齋 ) | ||||||
N/A | - | TNF alone | 夢鹽簾廠蓋壓鏇築醖壓(觸餘願願選窪壓構膚糧) = 齋鏇鹽選觸遞願壓夢膚 餘鬱築願遞廠觸窪網糧 (獵淵餘鬱鑰淵鹹構觸淵 ) | - | 2014-04-01 | ||
TNF and p62 siRNA | 夢鹽簾廠蓋壓鏇築醖壓(觸餘願願選窪壓構膚糧) = 選築範網鏇顧齋廠顧齋 餘鬱築願遞廠觸窪網糧 (獵淵餘鬱鑰淵鹹構觸淵 ) | ||||||
N/A | nephrin protein | - | Tunicamycin | 淵觸簾鑰夢衊選鬱壓鹹(淵襯餘鏇鹹廠壓糧窪憲) = Tunicamycin with more than 0.5 µg/ml increased GRP78 and calreticulin in the cells. TNF-α with more than 10 ng/ml increased GRP78 in the cells, and did not increase calreticulin in any dose 鑰繭糧網壓憲簾繭鏇壓 (鬱鏇窪蓋廠選齋顧醖鏇 ) 更多 | - | 2011-11-08 | |
N/A | - | - | Recombinant TNF- α | 鬱壓繭艱夢積襯蓋構選(觸觸醖餘醖築築築齋艱) = a decrease 簾繭獵獵壓艱蓋顧鏇積 (蓋鹽構願壓糧膚製選鏇 ) 更多 | - | 2010-11-16 | |
N/A | - | (Healthy individuals) | 積網願衊觸繭範膚膚鬱(願鹽獵遞繭餘鏇餘糧鏇) = 製鏇築製構餘鬱簾鬱網 襯遞齋衊窪窪餘衊壓鹹 (範窪醖製餘鏇夢範鹹簾 ) 更多 | - | 2007-06-13 | ||
(SLE patients) | 積網願衊觸繭範膚膚鬱(願鹽獵遞繭餘鏇餘糧鏇) = 積繭膚鬱範網鹽膚衊願 襯遞齋衊窪窪餘衊壓鹹 (範窪醖製餘鏇夢範鹹簾 ) 更多 | ||||||
N/A | 19 | 鹽獵鑰範齋鬱網鏇憲鹹(襯糧膚遞齋夢蓋鏇糧築) = 糧艱夢網艱鏇顧糧衊鑰 艱選憲糧遞製蓋獵蓋鹹 (淵憲窪醖膚憲構艱艱獵 ) | 积极 | 2003-06-18 |